This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Beijing Tide Pharmaceutical Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Huifen Xu - Innovator in Pharmaceutical Chemistry
Introduction
Huifen Xu is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific diseases. Her work is characterized by a focus on innovative solutions for treating serious health conditions.
Latest Patents
Huifen Xu holds a patent for a compound known as 2, 4, 6-tri-substituted pyrimidine, which acts as an ATR kinase inhibitor. This compound is particularly relevant for treating ATR kinase-mediated diseases, including hyperplastic diseases such as cancers. The patent also includes a pharmaceutical composition of this compound, its use in treating ATR kinase-mediated diseases, and a method for preparing the pharmaceutical composition.
Career Highlights
Huifen Xu is currently employed at Beijing Tide Pharmaceutical Co., Ltd. Her role at the company allows her to engage in cutting-edge research and development, contributing to advancements in medical treatments. With her expertise, she has been able to navigate complex challenges in pharmaceutical innovation.
Collaborations
Huifen Xu collaborates with talented colleagues, including Yuanyuan Jiang and Yanping Zhao. These partnerships enhance her research efforts and foster a collaborative environment that drives innovation.
Conclusion
Huifen Xu's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to the development of ATR kinase inhibitors highlight the importance of research in combating serious diseases. Through her patents and collaborations, she continues to pave the way for future advancements in medicine.